From Name

From Email

To Name

To Email

Message

Investigating combinations in recurrent or metastatic cervical cancer

from Targeted Oncology

Investigating combinations in recurrent or metastatic cervical cancer Targeted Oncology Bradley Monk, MD, a professor on the Clinical Scholar Track at the University of Arizona College of Medicine, Phoenix and a gynecologic oncologist at Arizona Oncology, discusses the phase 1b/2 innovaTV 205 trial in patients with recurrent or metastatic cervical cancer. READ MORE

more